Related Articles
Astragaloside IV inhibits oxidized low‑density lipoprotein‑induced endothelial damage via upregulation of miR‑140‑3p Retraction in /10.3892/ijmm.2023.5220
Astragaloside IV prevents high glucose‑induced cell apoptosis and inflammatory reactions through inhibition of the JNK pathway in human umbilical vein endothelial cells
Astragaloside Ⅳ combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway
Astragaloside IV prevents endothelial dysfunction by improving oxidative stress in streptozotocin‑induced diabetic mouse aortas
Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo